Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors

Bone Marrow Transplantation

Volumn 25, Issue 5, 2000, Pages 545-548

  Miyamura, K ^b   Hamaguchi, M ^c   Taji, H ^c   Kanie, T ^c   Kohno, A ^c   Tanimoto, M ^c   Saito, H ^c   Kojima, S ^c   Matsuyama, T ^c   Kitaori, K ^c   Nagafuji, K ^c   Sato, T ^a   Kodera, Y ^c  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

Adenovirus; BMT; Hemorrhagic cystitis; Ribavirin

Indexed keywords

HLA ANTIGEN; RIBAVIRIN; VIDARABINE;

ADENOVIRUS; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESISTANCE; FEMALE; HEMORRHAGIC CYSTITIS; HLA MATCHING; HUMAN; MALE; PANCYTOPENIA; PRIORITY JOURNAL; SCHOOL CHILD; VIRUS INFECTION;

EID: 17044442190     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702195     Document Type: Article

References (25)

1. Brugieres L, Hartmann O, Travagli JP et al. Hemorrhagic cystitis following high-dose chemotherapy and hone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol 1989; 7: 194-199.
2. Miyamura K, Takeyama K, Kojima S et al. Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 533-535.
3. Atkinson K, Biggs J, Noble G et al. Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis. Bone Marrow Transplant 1987; 2: 385-394.
4. Seber A, Shu XO, Defor T et al. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999; 23: 35-40.
5. Arthur RR, Shah KV, Baust SJ et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. New Engl J Med 1986; 315: 230-234.
6. Numazaki Y, Shigeta S, Kumasaka T et al. Acute hemorrhagic cystitis in children. Isolation of adenovirus type II. New Engl J Med 1968; 278: 700-704.
7. Zahradnik JM, Spencer MJ, Porter DD. Adenovirus infection in the immunocompromised patient. Am J Med 1980; 68: 725-732.
8. Fiala M, Payne JE, Berne TV et al. Role of adenovirus type 11 in hemorrhagic cystitis secondary to immunosuppression. J Urol 1974; 112: 595-597.
9. Miyamura K, Minami S, Matsuyama T et al. Adenovirus-induced late onset hemorrhagic cystitis following allogeneic bone marrow transplantation (letter). Bone Marrow Transplant 1987; 2: 109-110.
10. Ambinder RF, Burns W, Forman M et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Intern Med 1986; 146: 1400-1401.
11. Shields AF, Hackman RC, Fife KH et al. Adenovirus infections in patients undergoing bone marrow transplantation. New Eng J Med 1985; 312: 529-533.
12. Flomenberg P, Babbitt J, Drobyski WR et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Inject Dis 1994; 169: 775-781.
13. Kohno A, Takeyama K, Narabayashi M et al. Hemorrhagic cystitis associated with allogeneic and autologous bone marrow transplantation for malignant neoplasms in adults. Jap J Clin Oncol 1993; 23: 46-52.
14. Childs R, Sanchez C, Engler H et al. High incidence of adeno-and polyomavirus-induced hemorrhagic cystits in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 1998; 22: 889-894.
15. Trigg ME, O'Reilly J, Rumelhart S et al. Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis. J Urol 1990; 143: 92-94.
16. Cassano WF. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 7: 247-248.
17. Murphy GF, Wood DP Jr, McRoberts JW et al. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J Urol 1993; 149: 565-566.
18. Liles WC, Gushing H, Holt S et al. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin (see comments). Bone Marrow Transplant 1993; 12: 409-412.
19. Hromas R, Clark C, Blanke C et al. Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation (letter: comment). Bone Marrow Transplant 1994; 14: 663-664.
20. Jurado M, Navarro JM, Hernandez J et al. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin. Bone Marrow Transplantation 1995; 15: 651-652.
21. Mann D, Moreb J, Smith S et al. Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report. J Infect 1998; 36: 227-228.
22. Sao H, Kitaori K, Kasai M et al. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-versus-host disease in allogeneic bone marrow transplantation results of phase I-II trial. Int J Hematol 1999; 69: 27-35.
23. Paroni R, Del Puppo M, Borghi C et al. Pharmacokinetics of ribavirin and urinary excretion of major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers. Int J Clin Pharmacol 1989; 27: 302-307.
24. Hromas R, Cornetta K, Srour E et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T cell-depleted bone marrow transplantation (letter). Blood 1994; 84: 1689-1690.
25. + T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J Virol 1996; 70: 6314-6322.